Effect of Acetyl tributyl citrate on bone metabolism based on network toxicology and molecular docking technology

Xuan Lin1, Kun Lin2, Yue Lai3

  • 1Central Laboratory, Affiliated Hospital of Putian University, Putian, Fujian Province 351100, China; Department of Environmental and Biological Engineering, Putian University, Putian, Fujian Province 351100, China.

Insights

Acetyl tributyl citrate (ATBC) impairs osteoblast function and bone metabolism by downregulating key epigenetic regulators. This study reveals molecular mechanisms linking ATBC exposure to potential orthopedic disorders.

Area of Science:

  • Environmental Health
  • Molecular Biology
  • Bone Metabolism

Background:

  • Environmental contaminants like Acetyl tributyl citrate (ATBC) can impact human health.
  • Understanding the molecular basis of ATBC's effects on bone metabolism is crucial for public health.

Purpose of the Study:

  • To elucidate the molecular mechanisms of ATBC's impact on bone metabolism.
  • To identify key molecular targets and signaling pathways affected by ATBC.

Main Methods:

  • Bioinformatic analyses (ChEMBL, STITCH, GeneCards, OMIM, STRING, Cytoscape, Metascape) to identify ATBC targets and pathways.
  • Molecular docking simulations (AutoDock) to confirm ATBC-target interactions.
  • In vitro experiments using osteoblasts (MC3T3-E1) exposed to ATBC.

Main Results:

  • Ten core molecular targets and several key signaling pathways (e.g., thyroid hormone, FOXO, insulin) were identified.
  • Low-dose ATBC (100 μM) impaired osteoblast proliferation and migration.
  • ATBC exposure downregulated key epigenetic regulators (KDM1A, EP300, HDAC2) in osteoblasts.

Conclusions:

  • ATBC disrupts bone metabolism at the cellular level by affecting epigenetic regulators.
  • This study provides a molecular framework for understanding ATBC-induced bone disorders.
  • Findings may inform strategies for preventing orthopedic issues related to ATBC exposure.